BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 23640530)

  • 1. Oral anticoagulant therapies: balancing the risks.
    Nutescu EA
    Am J Health Syst Pharm; 2013 May; 70(10 Suppl 1):S3-11. PubMed ID: 23640530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing a management plan for oral anticoagulant reversal.
    Dager WE
    Am J Health Syst Pharm; 2013 May; 70(10 Suppl 1):S21-31. PubMed ID: 23640529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of anticoagulation intensity and management of bleeding with old and new oral anticoagulants.
    Liew A; Eikelboom JW; O'Donnell M; Hart RG
    Can J Cardiol; 2013 Jul; 29(7 Suppl):S34-44. PubMed ID: 23790596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Ansell J; Hirsh J; Poller L; Bussey H; Jacobson A; Hylek E
    Chest; 2004 Sep; 126(3 Suppl):204S-233S. PubMed ID: 15383473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Thrombosis and Haemostasis.
    Baker RI; Coughlin PB; Gallus AS; Harper PL; Salem HH; Wood EM;
    Med J Aust; 2004 Nov; 181(9):492-7. PubMed ID: 15516194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An update of consensus guidelines for warfarin reversal.
    Tran HA; Chunilal SD; Harper PL; Tran H; Wood EM; Gallus AS;
    Med J Aust; 2013 Mar; 198(4):198-9. PubMed ID: 23451962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Research progress of oral anticoagulants in patients with liver diseases].
    Zhan SP; Tang M; Liu F; Xia PY
    Zhonghua Gan Zang Bing Za Zhi; 2018 Nov; 26(11):873-876. PubMed ID: 30616327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A feasibility study of continuing dose-reduced warfarin for invasive procedures in patients with high thromboembolic risk.
    Larson BJ; Zumberg MS; Kitchens CS
    Chest; 2005 Mar; 127(3):922-7. PubMed ID: 15764777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic interventions for reversing the effects of oral anticoagulants.
    Kalus JS
    Am J Health Syst Pharm; 2013 May; 70(10 Suppl 1):S12-21. PubMed ID: 23640528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perioperative management of patients with atrial fibrillation receiving anticoagulant therapy.
    Omae T; Koh K; Kumemura M; Sakuraba S; Katsuda Y
    J Anesth; 2019 Aug; 33(4):551-561. PubMed ID: 31069541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug Treatment of Venous Thromboembolism in the Elderly.
    Boey JP; Gallus A
    Drugs Aging; 2016 Jul; 33(7):475-90. PubMed ID: 27255713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. European guidelines on perioperative venous thromboembolism prophylaxis: Patients with preexisting coagulation disorders and after severe perioperative bleeding.
    Ahmed A; Kozek-Langenecker S; Mullier F; Pavord S; Hermans C;
    Eur J Anaesthesiol; 2018 Feb; 35(2):96-107. PubMed ID: 29112549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peri-procedural management of patients taking oral anticoagulants.
    Daniels PR
    BMJ; 2015 Jul; 351():h2391. PubMed ID: 26174061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of bleeding and reversal strategies for oral anticoagulants: clinical practice considerations.
    Nutescu EA; Dager WE; Kalus JS; Lewin JJ; Cipolle MD
    Am J Health Syst Pharm; 2013 Nov; 70(21):1914-29. PubMed ID: 24128967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial.
    Healey JS; Eikelboom J; Douketis J; Wallentin L; Oldgren J; Yang S; Themeles E; Heidbuchel H; Avezum A; Reilly P; Connolly SJ; Yusuf S; Ezekowitz M;
    Circulation; 2012 Jul; 126(3):343-8. PubMed ID: 22700854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Has the era of warfarin terminated?].
    Pavlova TV; Dupliakov DV; Kuzina TN
    Angiol Sosud Khir; 2014; 20(1):16-20. PubMed ID: 24722016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of bleeding with oral anticoagulants in patients with atrial fibrillation.
    Bosch J; Eikelboom JW
    Hamostaseologie; 2015; 35(4):351-7. PubMed ID: 26013362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy Insight: management of urology patients taking long-term warfarin anticoagulation therapy.
    Daniels PR
    Nat Clin Pract Urol; 2005 Jul; 2(7):343-50. PubMed ID: 16474787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulation patient self-monitoring in the United States: considerations for clinical practice adoption.
    Nutescu EA; Bathija S; Sharp LK; Gerber BS; Schumock GT; Fitzgibbon ML
    Pharmacotherapy; 2011 Dec; 31(12):1161-74. PubMed ID: 22122179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory and Clinical Monitoring of Direct Acting Oral Anticoagulants: What Clinicians Need to Know.
    Conway SE; Hwang AY; Ponte CD; Gums JG
    Pharmacotherapy; 2017 Feb; 37(2):236-248. PubMed ID: 27983747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.